Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

Apellis Pharmaceuticals, Inc.

APLS•NASDAQ
Healthcare
Biotechnology
$40.23
$23.14(135.40%)
U.S. Market opens in 14h 3m

Apellis Pharmaceuticals, Inc. (APLS) Stock Technical Analysis & Trading Signals

Live technical indicators, trading signals, and momentum insights for Apellis Pharmaceuticals, Inc. (NASDAQ:APLS).

Disclaimer for Technical Analysis Page

The technical indicators and trading signals shown on this page are for informational purposes only and do not constitute financial advice. Stock market investments involve risk, and past performance is not a guarantee of future results. Always conduct your own research or consult a licensed financial advisor before making investment decisions.Read our Full Disclaimer

APLS Technical Analysis Summary

Apellis Pharmaceuticals, Inc. stock currently shows a bullish trend, supported by momentum and strong buying pressure.

Overall Sentiment:Buy
Momentum:Bullish to Bearish Risk (RSI: 87.43)
Trend Strength:Very Strong (ADX: 45.38)
Volatility:High (ATR: 2.43)
Support/Resistance:$9.88 – $29.29 (Bollinger Bands)

Technical conditions suggest Apellis Pharmaceuticals, Inc. is consolidating, awaiting a decisive move.

Momentum Indicators

RSI (14): 87.43

Bearish
Overbought, selling pressure may emerge.

Stochastic %K: 37.65

Bearish
Momentum remains weak below midpoint.

Williams %R: -0.93

Bearish
Overbought levels may trigger correction.

Rate of Change (ROC): 107.59

Strongly Bullish
Strong upside momentum.

Takeaway:Apellis Pharmaceuticals, Inc. shows steady upward momentum, supported by improving signals.

Trend & Volatility

MACD: 0.74

Bullish
Bullish, trend momentum is strengthening.

ADX: 45.38

Very Strong
Very strong trend, powerful directional momentum.

ATR (14): 2.43

Medium
Medium volatility, healthy price movement.

CCI (14): 466.67

Bearish Risk
Bearish risk, overbought levels suggest caution.

Takeaway:Apellis Pharmaceuticals, Inc. shows a firm trend supported by momentum, though one signal suggests caution.

Support & Resistance indicators
Bollinger Bands
Upper Band
$29.29
Middle Band (SMA 20)
$19.58
Lower Band
$9.88
Current Position
Above Upper Band

Takeaway:Apellis Pharmaceuticals, Inc. trades near the upper band, signaling overbought conditions and risk of pullback.

Keltner Channels
Upper Channel
$25.47
Middle Line (EMA 20)
$20.62
Lower Channel
$15.77
Squeeze Status
No Squeeze

Takeaway:Apellis Pharmaceuticals, Inc. trades near the upper channel, signaling resistance and risk of pullback.

Volume & Money Flow Analysis
On-Balance Volume34.24M
Money Flow Index89.65Bearish risk, overbought conditions may trigger pullback.
Relative Vigor Index76.09Bullish, price momentum strongly favors buyers.

Overall Takeaway:APLS shows overheated money flow, with risk of pullback from overbought conditions.

Technical Trading Signals Summary
Based on the current technical analysis of Apellis Pharmaceuticals, Inc., here are the key trading signals and recommendations:

Bullish Signals

RSI above 50 → positive momentum from buyers.

MACD above 0 → bullish trend confirmation.

ADX above 20 → strong underlying trend.

Price trading above middle Bollinger Band → mid-term support intact.

Bearish Signals

Price near upper Bollinger Band → potential resistance and pullback risk.

MFI above 80 → overbought conditions may limit upside.

Overall Recommendation:Apellis Pharmaceuticals, Inc. currently shows a Buy with caution signal — momentum and trend strength are positive, but price is close to resistance and may face short-term pullbacks.

Technical Analysis FAQ